Evidence-based·Last reviewed May 30, 2026·How we grade evidence

Lactobacillus gasseri

ProbioticPantetheine

Useful mainly for people wanting a strain-specific probiotic for modest visceral-fat reduction or as an adjunct in H. pylori care.

Quick decision guide

May help most

People wanting a strain-specific probiotic for modest visceral-fat reduction or as an adjunct in H. pylori care

Common dosing range

1–10 billion CFU/day

When to expect effects

Weeks (8–12 weeks for weight outcomes)

Watch out for

Small bacteremia risk in immunocompromised or critically ill people

What is it

Lactobacillus gasseri is a probiotic bacterium found naturally in the human gut, mouth, and vagina. It has been studied for weight management, women's health, and gastrointestinal applications, with several specific strains commercially available.

Is it worth it for you?

Use this as a quick fit check, not a diagnosis.

Worth considering if

You want a strain-specific adjunct (e.g., BNR17 or SBT2055) for abdominal fat alongside diet
You are using it to support H. pylori eradication with standard therapy
You will commit to 8–12 weeks of consistent use

Probably skip if

You are severely immunocompromised or critically ill
You expect it to replace diet and exercise for weight loss
You assume any L. gasseri product matches the studied strains

Evidence at a glance

abdominal and visceral fat reduction

Limited Evidence
Effect
Small reductions in visceral fat
Best fit
Adults with excess abdominal fat using a studied strain (BNR17, SBT2055) with diet
Time
Weeks (often 12)

helicobacter pylori suppression (adjunct)

Limited Evidence
Effect
Modest improvement in eradication or tolerability
Best fit
Adults undergoing H. pylori eradication therapy
Time
Weeks (during the treatment course)

vaginal flora support

Limited Evidence
Effect
Modest, preliminary
Best fit
Women aiming to maintain healthy vaginal flora, often as an adjunct to treatment
Time
Weeks

Evidence for 3 uses

AI-assisted evidence assessment — talk to your doctor before relying on any single supplement.

abdominal and visceral fat reduction

Supplement benefit
Limited Evidence

Trials of specific strains such as BNR17 and SBT2055 show small reductions in visceral and abdominal fat over about 12 weeks, possibly via effects on fat absorption and appetite hormones. Effect sizes are modest, regain can occur after stopping, and results are strain-specific.

Effect size
Small reductions in visceral fat
Time to effect
Weeks (often 12)
Best fit
Adults with excess abdominal fat using a studied strain (BNR17, SBT2055) with diet
Less likely
People expecting substantial weight loss without lifestyle change

Bottom line: A modest, strain-specific adjunct for abdominal fat, not a substitute for diet and exercise.

Evidence is mixed

Benefits appear in particular strains and trials but are small and not consistently reproduced.

helicobacter pylori suppression (adjunct)

Disease adjunct
Limited Evidence

As an adjunct to standard eradication regimens, some L. gasseri-containing probiotics may modestly improve eradication rates or reduce antibiotic-related side effects. Evidence is limited and mixed across strains and protocols.

Effect size
Modest improvement in eradication or tolerability
Time to effect
Weeks (during the treatment course)
Best fit
Adults undergoing H. pylori eradication therapy

Bottom line: A possible adjunct to standard H. pylori therapy, not a standalone treatment.

vaginal flora support

Supplement benefit
Limited Evidence

L. gasseri is a dominant species in healthy vaginal flora and may help maintain a low-pH, lactic-acid environment that resists pathogen overgrowth. Clinical evidence is limited and strain-dependent.

Effect size
Modest, preliminary
Time to effect
Weeks
Best fit
Women aiming to maintain healthy vaginal flora, often as an adjunct to treatment

Bottom line: Plausible and preliminarily supportive for vaginal flora, but evidence is thin.

How it works

L. gasseri colonizes the gut and other mucosal surfaces, producing lactic acid and bacteriocins that inhibit the growth of competing organisms. It adheres to intestinal epithelial cells and may strengthen the gut barrier. Some L. gasseri strains produce gassericins, antimicrobial peptides that can inhibit pathogenic bacteria. A proposed mechanism for weight-related effects involves modulation of dietary fat absorption. Trials of L. gasseri BNR17 and SBT2055 have shown small reductions in visceral and abdominal fat, possibly through influences on lipid metabolism, appetite-regulating hormones, and the broader gut microbiota composition. The effect sizes are modest and not consistently large enough to substitute for diet and exercise. In women's health applications, L. gasseri is one of the dominant species in healthy vaginal flora and may support maintenance of a low-pH, lactic-acid-producing environment that resists overgrowth of pathogens. Strain-specific effects mean that research on one L. gasseri strain does not necessarily apply to others.

How to take it

1. Typical dose
1–10 billion CFU/day of a defined strain
2. Timing
Same time daily, with or without food; a small meal may aid survival
3. With food
With or without food
4. How long to try
8–12 weeks or longer for weight-related goals

What to track

Waist circumference or visceral fat
Body weight
Digestive symptoms
GI tolerance in the first weeks

3 commercial forms

Compare the main delivery options and what they’re best suited for.

L. gasseri SBT2055

Most-studied strain for fat-reduction outcomes. Used in fermented dairy products and supplements in Japan.

Studied at low doses (~100 million CFU) for weight effects

L. gasseri BNR17

Studied for weight management and menstrual health applications.

Acid-stable, isolated from human breast milk

L. gasseri CUL-09

Common in supplement formulations targeting women's health.

Used in multi-strain blends

Safety

Know the common side effects, key cautions, and who should avoid it.

Common side effects

Mild gasBloatingTransient digestive changes

Serious risks

  • Rare bacteremia in immunocompromised or critically ill people

Who should avoid it

  • Severely immunocompromised people
  • People with central venous catheters
  • Critically ill patients (without physician input)

Pregnancy & breastfeeding

Generally well tolerated in pregnancy and breastfeeding, but confirm strain and check for dairy carriers if allergic.

Interactions

AntibioticsModerate

Can kill the probiotic; separate doses by at least 2 hours

Immunosuppressive medicationsModerate

May raise the small risk of bacterial translocation

Food sources

Some fermented dairy (Japanese-market products)

Amount
Variable; specific strains in branded products
%DV

Human breast milk

Amount
Natural source, particularly for BNR17
%DV

Choosing a product

What to look for on the label — and what to be skeptical of.

Look for

Named, studied strain (e.g., BNR17, SBT2055)
Guaranteed CFU through end of shelf life
Storage instructions (refrigeration if required)

Be skeptical of

Melts belly fat
Balances all gut bacteria
Cures digestive disease

Frequently asked questions

Can L. gasseri really help me lose weight?

Trials show small reductions in abdominal and visceral fat (typically 1 to 4 percent) over 8 to 12 weeks. It is not a substitute for diet and exercise but may modestly support fat-reduction efforts in some people.

Which L. gasseri strain is best for weight?

SBT2055 has the most research on fat-related outcomes. BNR17 has also been studied. Look for specific strain designations on labels.

Is L. gasseri safe in pregnancy?

L. gasseri is generally well tolerated in pregnancy, but discuss with your obstetric provider before starting any supplement during pregnancy.

Can L. gasseri help with vaginal health?

It is a normal inhabitant of healthy vaginal flora. Some trials suggest oral or vaginal supplementation may support recovery from bacterial vaginosis when combined with standard treatment.

How long should I take L. gasseri before judging effects?

For weight-related outcomes, trials typically run 8 to 12 weeks. For digestive or vaginal health, effects may be seen within a few weeks.

References by claim

abdominal and visceral fat reduction

Kim et al., 2018PubMed (2018) link

helicobacter pylori suppression (adjunct)

Deguchi et al., 2012PMC (2012) link

vaginal flora support

Zhou et al., 2024PubMed (2024) link

de et al., 2019PubMed (2019) link

Track Lactobacillus gasseri with Pilora

Set up dose reminders, check interactions, and join the community in the Pilora iPhone app.

Coming to App Store
Evidence-based·Last reviewed May 30, 2026·Evidence current as of May 30, 2026·How we grade evidence

Disclaimer: These statements have not been evaluated by the FDA. This page is educational, not a substitute for personalized medical advice. Evidence grades are AI-assisted assessments — talk to your doctor before starting any new supplement, especially if you’re pregnant, breastfeeding, on medications, or managing a chronic condition.